Transcripts

Arrowhead Pharmaceuticals (ARWR) earnings call transcripts

Earnings call transcripts for Arrowhead Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q3 2026 earnings call

    Management framed SHASTA as a de-risking catalyst for an accelerated SHTG launch, while emphasizing education, payer execution, and scalable commercialization.

    Aug 04, 2026Confident0.86